The latest cancer drugs news
Browsing: Cancer Drug News
ASCO 2017: Adding a Second HER2 Blocker May Lower Chance of Invasive Breast Cancer for Some Women
A phase III clinical trial of 4,805 women with HER2-positive breast cancer suggests adding a…
ASCO 2017: New Drug Shows Durable Efficacy Across Diverse Pediatric and Adult Cancers
Scientists may have developed the first targeted, oral, tumour-type agnostic therapy – a cancer medicine…
ASCO 2017: Abiraterone Slows Advanced Prostate Cancer, Helps Patients Live Longer
A clinical trial of nearly 2,000 men shows that adding abiraterone acetate (Zytiga) to a…
ASCO 2017: Olaparib slows growth of BRCA-related metastatic breast cancer
Findings from a phase III clinical trial of about 300 women may introduce PARP inhibitors…
Tamoxifen protects against obesity-related metabolic disorders
New study in mice helps scientists understand how tamoxifen reduces food intake and prevents fat…
Breakthrough study stops fat-eating prostate cancer cells
Patients with castration resistant prostate cancer (CRPC) usually have a poor prognosis. In part, this…
Phase II data of brigantinib for relapsed and metastatic NSCLC released
Data from the pivotal Phase 2 ALTA clinical trial evaluating brigatinib in patients with crizotinib-refractory, anaplastic lymphoma…
Osimertinib improves symptoms in advanced lung cancer patients
Osimertinib improves cancer-related symptoms in patients with advanced lung cancer, according to an analysis of…
England’s Cancer Drugs Fund ‘failed to deliver meaningful value to patients and society’
Analysis of the drugs that were approved for use by the NHS Cancer Drugs Fund…
Regular use of aspirin can lower risk of breast cancer for women
The use of low-dose aspirin (81 mg) reduces the risk of breast cancer in women,…